PL3046548T3 - Tabletka zawierająca krospowidon - Google Patents
Tabletka zawierająca krospowidonInfo
- Publication number
- PL3046548T3 PL3046548T3 PL14766730T PL14766730T PL3046548T3 PL 3046548 T3 PL3046548 T3 PL 3046548T3 PL 14766730 T PL14766730 T PL 14766730T PL 14766730 T PL14766730 T PL 14766730T PL 3046548 T3 PL3046548 T3 PL 3046548T3
- Authority
- PL
- Poland
- Prior art keywords
- crospovidone
- tablet
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/424—Oxazoles condensed with heterocyclic ring systems, e.g. clavulanic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/429—Thiazoles condensed with heterocyclic ring systems
- A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP13185368 | 2013-09-20 | ||
| EP14766730.7A EP3046548B1 (en) | 2013-09-20 | 2014-09-18 | Tablet comprising crospovidone |
| PCT/EP2014/069852 WO2015040093A1 (en) | 2013-09-20 | 2014-09-18 | Tablet comprising crospovidone |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3046548T3 true PL3046548T3 (pl) | 2020-07-13 |
Family
ID=49223642
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL14766730T PL3046548T3 (pl) | 2013-09-20 | 2014-09-18 | Tabletka zawierająca krospowidon |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US10159647B2 (pl) |
| EP (1) | EP3046548B1 (pl) |
| CN (1) | CN105555261B (pl) |
| DK (1) | DK3046548T3 (pl) |
| ES (1) | ES2780874T3 (pl) |
| HU (1) | HUE048496T2 (pl) |
| PL (1) | PL3046548T3 (pl) |
| PT (1) | PT3046548T (pl) |
| RS (1) | RS60054B1 (pl) |
| SI (1) | SI3046548T1 (pl) |
| WO (1) | WO2015040093A1 (pl) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2937365C (en) | 2016-03-29 | 2018-09-18 | F. Hoffmann-La Roche Ag | Granulate formulation of 5-methyl-1-phenyl-2-(1h)-pyridone and method of making the same |
| US11524005B2 (en) | 2019-02-19 | 2022-12-13 | Gilead Sciences, Inc. | Solid forms of FXR agonists |
| KR20210136081A (ko) * | 2019-03-11 | 2021-11-16 | 길리애드 사이언시즈, 인코포레이티드 | 화합물의 제제 및 그의 용도 |
| EP4185126A1 (en) * | 2020-07-24 | 2023-05-31 | DSM IP Assets B.V. | New fast dissolvable tablets |
| CN113274357B (zh) * | 2021-05-28 | 2022-12-27 | 广州白云山医药集团股份有限公司白云山制药总厂 | 一种阿莫西林药物及其制备方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SI9200139A (en) | 1992-07-08 | 1994-03-31 | Lek Tovarna Farmacevtskih | New inclusion complex of clavulanic acid with hydrophylyc and hydropholyc beta-cyclodextrin derivates for production of them |
| US20030124187A1 (en) * | 1997-02-14 | 2003-07-03 | Smithkline Beecham Laboratoires Pharmaceutiques, | Pharmaceutical formulations comprising amoxycillin and clavulanate |
| IL131201A (en) * | 1997-02-14 | 2005-06-19 | Smithkline Beecham Lab | Pharmaceutical formulations comprising amoxycillin and clavulanate |
| US6878386B1 (en) * | 1999-04-13 | 2005-04-12 | Beecham Pharmaceuticals (Pte) Limited | Method of treating a bacterial infection comprising amoxycillin and potassium clavulanate |
| US20020006433A1 (en) * | 1999-04-29 | 2002-01-17 | Nigel P. Davidson | Pharmaceutical formulations |
-
2014
- 2014-09-18 EP EP14766730.7A patent/EP3046548B1/en active Active
- 2014-09-18 DK DK14766730.7T patent/DK3046548T3/da active
- 2014-09-18 SI SI201431515T patent/SI3046548T1/sl unknown
- 2014-09-18 PL PL14766730T patent/PL3046548T3/pl unknown
- 2014-09-18 CN CN201480051679.5A patent/CN105555261B/zh active Active
- 2014-09-18 PT PT147667307T patent/PT3046548T/pt unknown
- 2014-09-18 RS RS20200214A patent/RS60054B1/sr unknown
- 2014-09-18 US US14/916,613 patent/US10159647B2/en active Active
- 2014-09-18 WO PCT/EP2014/069852 patent/WO2015040093A1/en not_active Ceased
- 2014-09-18 ES ES14766730T patent/ES2780874T3/es active Active
- 2014-09-18 HU HUE14766730A patent/HUE048496T2/hu unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP3046548A1 (en) | 2016-07-27 |
| ES2780874T3 (es) | 2020-08-27 |
| US10159647B2 (en) | 2018-12-25 |
| PT3046548T (pt) | 2020-03-04 |
| CN105555261A (zh) | 2016-05-04 |
| CN105555261B (zh) | 2020-02-11 |
| RS60054B1 (sr) | 2020-04-30 |
| SI3046548T1 (sl) | 2020-04-30 |
| EP3046548B1 (en) | 2020-02-12 |
| HUE048496T2 (hu) | 2020-07-28 |
| DK3046548T3 (da) | 2020-04-27 |
| WO2015040093A1 (en) | 2015-03-26 |
| US20160193153A1 (en) | 2016-07-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB201306312D0 (en) | Tablet case | |
| GB201322602D0 (en) | Pharmaceutical compounds | |
| IL240846A0 (en) | drug combination | |
| GB201302901D0 (en) | Ubuntu tablet | |
| GB201306610D0 (en) | Pharmaceutical compounds | |
| SG10201707135RA (en) | Drug combinations | |
| ZA201602047B (en) | Pharmaceutical compounds | |
| HUE048496T2 (hu) | Kroszpovidont tartalmazó tabletta | |
| IL241350A0 (en) | Subprevir tablets | |
| SI2946780T1 (sl) | Tableta, ki vsebuje 5-hidroksi-1h-imidazol-4-karboksamid | |
| GB201312386D0 (en) | Pharmaceutical compounds | |
| EP3069714A4 (en) | Tablet | |
| GB201317166D0 (en) | Pharmaceutical compounds | |
| GB201316662D0 (en) | Pharmaceutical Combination | |
| GB201316780D0 (en) | Pharmaceutical compounds | |
| GB201316791D0 (en) | Pharmaceutical Compounds | |
| GB201315733D0 (en) | Pharmaceutical compounds | |
| GB201315734D0 (en) | Pharmaceutical compounds | |
| GB201312464D0 (en) | Pharmaceutical compounds | |
| GB201308782D0 (en) | Pharmaceutical compounds | |
| GB201308780D0 (en) | Pharmaceutical compounds | |
| GB201308781D0 (en) | Pharmaceutical compounds | |
| PH32013000937S1 (en) | Tablet computer | |
| PH32013000939S1 (en) | Tablet computer | |
| PH32013000938S1 (en) | Tablet computer |